Drug Target Review – Issue 4 2020 36SHARES Share via Pinterest Reddit Buffer Xing WhatsApp Flipboard Posted: 26 November 2020 | Drug Target Review | No comments yet In this journal, find articles discussing antimicrobial resistance, exploring why inhibiting the interaction between SARS-CoV-2 and neuropilin-1 could help combat COVID-19, as well as how CRISPR can be used to enhance productivity in cell line development. Also in this issue, features on engineering new biologic drugs and precision medicine. Included in this issue: With regular news updates and feature articles, our COVID-19 hub has everything you need to keep up to date with R&D during the pandemic. Click below to visit: COVID-19 hub SCREENING Genetic screening to predict the risk of future diseases Pushpanathan Muthuirulan, Harvard University Antimicrobial resistance – a public health emergency on the horizon Jack Kay, University of Plymouth and Ingenza Ltd COVID-19 Development of a physiologically relevant lung model for understanding SARS-CoV-2 infection Lyle Armstrong, Newcastle University and Newcells Biotech Investigating cellular pathways driving severe COVID-19 with proteomics Mike Filbin, Massachusetts General Hospital LABEL FREE A label-free imaging technique for drug evaluation at single‑cell level Arno Germond, RIKEN Center for Biosystems Dynamics Research UPSTREAM BIOPROCESSING Biosynthetic polysaccharidebased drugs and nutraceuticals from non-animal sources Robert J Linhardt and Payel Datta, Rensselaer Polytechnic Institute NGS Tracking SARS-CoV- 2 with genome sequencing Nikki Withers, Drug Target Review GENOMICS Predicting COVID-19 susceptibility and severity Cathy Ball, AncestryDNA The rest of this content is restricted - login or subscribe free to access Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login. Why subscribe? Join our growing community of thousands of industry professionals and gain access to: quarterly issues in print and/or digital format case studies, whitepapers, webinars and industry-leading content breaking news and features our extensive online archive of thousands of articles and years of past issues ...And it's all free! Click here to Subscribe today Login here Related topicsAntimicrobials, Biologics, Cell culture, Disease research, Drug Development, Genomics, Imaging, Oncology, Therapeutics Related conditionsAntimicrobial resistance (AMR), Covid-19